# Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty

> **NCT02777749** · PHASE4 · COMPLETED · sponsor: **Columbia University** · enrollment: 155 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02777749
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-19
- **Primary completion:** 2017-09-19
- **Final completion:** 2017-11-01
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777749, "Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02777749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*